Vimarsana
Biggest News Aggregation in the World

Page 28 - Fda Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Approval Today - Breaking & Trending Today

FDA Approves Momelotinib for Myelofibrosis With Anemia - Vimarsana News

FDA Approves Momelotinib for Myelofibrosis With Anemia

The FDA has approved momelotinib (Ojjaara) for the treatment of adult patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis, and anemia.

Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease - Vimarsana News

Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease

/PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND)...

Will Celcuity's VIKTORIA-1 Hit The Target? - Vimarsana News

Will Celcuity's VIKTORIA-1 Hit The Target?

Shares of Celcuity Inc. (CELC) are down 34% from their 52-week high of $14.40, recorded in January of this year, to trade around $9..

Red Light, Health Insight: Science and Benefits Behind Red Light Therapy - Vimarsana News

Red Light, Health Insight: Science and Benefits Behind Red Light Therapy

Discover the healing potential of Red Light Therapy. Dive into its mechanism, applications, and science-backed benefits for skin, hair, pain relief, and more.

These 9 Stocks Touched New Highs - Vimarsana News

These 9 Stocks Touched New Highs

In the world of investing, timing is everything. Here are some healthcare stocks that touched new 52-week highs yesterday. If you have been following our stock reports, you would have noticed that we had profiled these very stocks long before they hit their recent highs.